---
title: "Iovance（IOVA）股價達到 52 周新高，分析師將其目標價提高了一倍"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278201849.md"
description: "Iovance Biotherapeutics Inc.（納斯達克代碼：IOVA）達到了新的 52 周高點，延續了三天的上漲趨勢，因為投資者在一家投資公司決定將該股票的目標價翻倍後購買了該股票。目前，該公司被列為 10 只值得關注的股票之一"
datetime: "2026-03-07T06:51:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278201849.md)
  - [en](https://longbridge.com/en/news/278201849.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278201849.md)
---

# Iovance（IOVA）股價達到 52 周新高，分析師將其目標價提高了一倍

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the 10 Stocks to Watch Right Now. Iovance climbed to a new 52-week high on Friday, extending a three-day run, as investors gobbled up shares after an investment firm doubled its price target for its stock. At intra-day trading, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) climbed to its highest price \[…\]

### 相關股票

- [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [IOVA.US](https://longbridge.com/zh-HK/quote/IOVA.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)

## 相關資訊與研究

- [鉅亨速報 - Factset 最新調查：Summit Therapeutics Inc(SMMT-US) EPS 預估上修至-1.2 元，預估目標價為 33.00 元](https://longbridge.com/zh-HK/news/282998825.md)
- [巨生醫細胞治療產品獲 SelectUSA Tech 醫療領域前 8 強 有助美國市場佈局](https://longbridge.com/zh-HK/news/282988767.md)
- [恆瑞醫藥注射用 SHR-A2102 獲納入突破性治療品種名單，適應症涉宮頸癌](https://longbridge.com/zh-HK/news/283069796.md)
- [鉅亨速報 - Factset 最新調查：美敦力公司 (MDT-US) EPS 預估下修至 5.52 元，預估目標價為 111.00 元](https://longbridge.com/zh-HK/news/282861471.md)
- [巨生醫細胞治療產品 MPB-2354 獲選 SelectUSA Tech 醫療領域前八強](https://longbridge.com/zh-HK/news/282972944.md)